Alnylam Pharmaceuticals | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Acadia Pharmaceuticals USD 822.38M 57.14M 2025-06
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 7.43B 1.22B 2025-06
Arrowhead Research USD 522.31M 161.91M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Moderna USD 9.4B 667M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Novartis USD 44.05B 729M 2024-12
PTC Therapeutics USD -206546000 20.79M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Takeda JPY 6.87T 69.82B 2025-06
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06
Xencor USD 620.35M 19.52M 2025-06


Alnylam Pharmaceuticals Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.